Transgene Biotek Ltd
BSE:526139

Watchlist Manager
Transgene Biotek Ltd Logo
Transgene Biotek Ltd
BSE:526139
Watchlist
Price: 6.36 INR -1.7% Market Closed
Updated: May 18, 2024

Intrinsic Value

526139 doesn't have a meaningful market cap.

Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. [ Read More ]

The intrinsic value of one TRABI stock under the Base Case scenario is hidden INR. Compared to the current market price of 6.36 INR, Transgene Biotek Ltd is hidden .

Key Points:
TRABI Intrinsic Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Backtest
Transgene Biotek Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TRABI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Transgene Biotek Ltd

Provide an overview of the primary business activities
of Transgene Biotek Ltd.

What unique competitive advantages
does Transgene Biotek Ltd hold over its rivals?

What risks and challenges
does Transgene Biotek Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Transgene Biotek Ltd.

Provide P/S
for Transgene Biotek Ltd.

Provide P/E
for Transgene Biotek Ltd.

Provide P/OCF
for Transgene Biotek Ltd.

Provide P/FCFE
for Transgene Biotek Ltd.

Provide P/B
for Transgene Biotek Ltd.

Provide EV/S
for Transgene Biotek Ltd.

Provide EV/GP
for Transgene Biotek Ltd.

Provide EV/EBITDA
for Transgene Biotek Ltd.

Provide EV/EBIT
for Transgene Biotek Ltd.

Provide EV/OCF
for Transgene Biotek Ltd.

Provide EV/FCFF
for Transgene Biotek Ltd.

Provide EV/IC
for Transgene Biotek Ltd.

Compare the intrinsic valuations
of Transgene Biotek Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Transgene Biotek Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Transgene Biotek Ltd compared to its peers.

Compare the P/E ratios
of Transgene Biotek Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Transgene Biotek Ltd with its peers.

Analyze the financial leverage
of Transgene Biotek Ltd compared to its main competitors.

Show all profitability ratios
for Transgene Biotek Ltd.

Provide ROE
for Transgene Biotek Ltd.

Provide ROA
for Transgene Biotek Ltd.

Provide ROIC
for Transgene Biotek Ltd.

Provide ROCE
for Transgene Biotek Ltd.

Provide Gross Margin
for Transgene Biotek Ltd.

Provide Operating Margin
for Transgene Biotek Ltd.

Provide Net Margin
for Transgene Biotek Ltd.

Provide FCF Margin
for Transgene Biotek Ltd.

Show all solvency ratios
for Transgene Biotek Ltd.

Provide D/E Ratio
for Transgene Biotek Ltd.

Provide D/A Ratio
for Transgene Biotek Ltd.

Provide Interest Coverage Ratio
for Transgene Biotek Ltd.

Provide Altman Z-Score Ratio
for Transgene Biotek Ltd.

Provide Quick Ratio
for Transgene Biotek Ltd.

Provide Current Ratio
for Transgene Biotek Ltd.

Provide Cash Ratio
for Transgene Biotek Ltd.

What is the historical Revenue growth
over the last 5 years for Transgene Biotek Ltd?

What is the historical Net Income growth
over the last 5 years for Transgene Biotek Ltd?

What is the current Free Cash Flow
of Transgene Biotek Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Transgene Biotek Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Transgene Biotek Ltd

Current Assets 9.6m
Cash & Short-Term Investments 105.1k
Receivables 84.5k
Other Current Assets 9.4m
Non-Current Assets 1.4B
Long-Term Investments 950.2k
PP&E 17.1m
Intangibles 65.6m
Other Non-Current Assets 1.3B
Current Liabilities 107.7m
Accounts Payable 2m
Short-Term Debt 85.5m
Other Current Liabilities 20.1m
Non-Current Liabilities 1.2B
Long-Term Debt 50.1m
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
Transgene Biotek Ltd

Revenue
1.9m INR
Cost of Revenue
-642.7k INR
Gross Profit
1.3m INR
Operating Expenses
-20.2m INR
Operating Income
-19m INR
Other Expenses
332.3k INR
Net Income
-18.6m INR

Free Cash Flow Analysis
Transgene Biotek Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

TRABI Profitability Score
Profitability Due Diligence

Transgene Biotek Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive Free Cash Flow
Exceptional 1-Year Revenue Growth
hidden
Profitability
Score

Transgene Biotek Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

TRABI Solvency Score
Solvency Due Diligence

Transgene Biotek Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Transgene Biotek Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRABI Price Targets Summary
Transgene Biotek Ltd

There are no price targets for TRABI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Transgene Biotek Ltd

Shareholder Return

TRABI Price
Transgene Biotek Ltd

1M 1M
-17%
6M 6M
-16%
1Y 1Y
+70%
3Y 3Y
+56%
5Y 5Y
+46%
10Y 10Y
+58%
Annual Price Range
6.36
52w Low
3.74
52w High
11.98
Price Metrics
Average Annual Return 4.48%
Standard Deviation of Annual Returns 70.23%
Max Drawdown -51%
Shares Statistics
Market Capitalization 481.9m INR
Shares Outstanding 75 770 000
Percentage of Shares Shorted
N/A

TRABI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Transgene Biotek Ltd Logo
Transgene Biotek Ltd

Country

India

Industry

Biotechnology

Market Cap

481.9m INR

Dividend Yield

0%

Description

Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. The company is headquartered in Medak, Telangana. The firm is engaged in a single business segment of Bulk Drugs. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. The firm offers TrabiAAV, which is a platform for the delivery of micro ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy. The company also offers monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-0404, is used for the treatment of metastatic liver cancer. Its TBL-1203, is used to strengthen cell-mediated immunity and complete elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus is a drug that suppresses the immune system and is mainly used to prevent rejection of transplanted organs.

Contact

TELANGANA
Medak
Plot 68, 69 & 70, IDA Bollaram, ANRICH Industrial Area, IDA Bollaram
+914065589499
http://www.transgenebiotek.com/

IPO

1992-09-23

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one TRABI stock?

The intrinsic value of one TRABI stock under the Base Case scenario is hidden INR.

Is TRABI stock undervalued or overvalued?

Compared to the current market price of 6.36 INR, Transgene Biotek Ltd is hidden .